1. SAT0213 Low-Dose Imatinib in the Treatment of Scleroderma Pulmonary Involvement: Results of a Phase II Pilot Study. (23rd January 2014) Authors: Fraticelli, P.; Pomponio, G.; Gabrielli, B.; Riboldi, P.; Ferraccioli, G.; Giacomelli, R.; Del Papa, N.; Bombardieri, S.; Malorni, W.; Gerli, R.; Lunardi, C.; Faggioli, P.; Corvetta, A.; Valentini, G.; Gabrielli, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗